Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
bioAffinity Technologies Inc. Warrant
BIAFW | US
0.26
USD0
0%
BIAFW | US
About bioAffinity Technologies Inc. Warrant
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
03/03/2026
Close
0.26
Open
0.22
High
0.26
Low
0.22
View Less
BIAFW | US
Risk
92.6
Sharpe
-0.11
Luna's Score
48/100
Recommendation
Hold
Luna says (BIAFW | US)
What's Working
Positive Momentum
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
92.6%1 month
92.6%3 months
177.1%6 months
333.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
0.40
Debt to assets
0.21
Ent. to EBITDA
-
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-8.03M
MarketCap
-
MarketCap(USD)
-
Div. yield
-
Op. margin
-87.08
Erngs. growth
-
Rev. growth
12.05K
Ret. on equity
-151.52
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.07
Range1M
0.07
Range3M
0.15
Volumes: Market Activity
Rel. volume
0.22
Price X volume
54.62
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 12.67 | - |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | - | 77.50 | - |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 177.15 | 59.59 | Riskier |
| Debt to Equity | 0.40 | -14.36 | Expensive |
| Debt to Assets | 0.21 | 0.34 | Cheaper |
| Market Cap | - | 13.71B | - |
